Tissue Factor Pathway Inhibitor (TFPI) Antibody

Este producto es parte de TFPI - Tissue factor pathway inhibitor
Product Graph
442€ (200 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Tissue Factor Pathway Inhibitor (TFPI) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx433382
tested applications
P-ELISA, WB

Description

TFPI Antibody is a Goat Polyclonal antibody against TFPI.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Tissue Factor Pathway Inhibitor (TFPI)
Immunogen: abx269016 - C-Terminus: C-VKIAYEEIFVKNM
Host
Goat
Reactivity
Human
Assay Type
Concentration: 0.5 mg/ml
Recommended Dilution
P-ELISA: 1/64000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Size 1
200 µl
Form
Liquid
Tested Applications
P-ELISA, WB
Buffer
Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
7035
NCBI Accession
NP_006278.1
Alias
EPI, LACI, TFI, TFPI1,Extrinsic pathway inhibitor,EPI
Background
Antibody anti-TFPI
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Tissue Factor Pathway Inhibitor (TFPI) is a crucial regulator of the extrinsic coagulation cascade, primarily inhibiting the tissue factor (TF)-factor VIIa complex and factor Xa to maintain hemostasis and prevent excessive thrombosis. It is a Kunitz-type serine protease inhibitor, produced mainly by endothelial cells, and circulates bound to lipoproteins or as a free plasma protein. TFPI acts as a feedback inhibitor that ensures balanced thrombin generation, thereby reducing the risk of pathological clot formation. Dysregulation or deficiency in TFPI has been linked to thrombotic disorders and cardiovascular diseases. Beyond its anticoagulant role, TFPI exhibits anti-inflammatory properties, reducing vascular inflammation and protecting against atherosclerosis. It is also involved in angiogenesis and endothelial cell function, making it significant in vascular biology.

Related Products

abx269016

Tissue Factor Pathway Inhibitor (TFPI) Peptide

Tissue Factor Pathway Inhibitor (TFPI) Peptide is a synthetic peptide. This peptide is used in the production of

Ver Producto